Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series) - Image 1

£129.36

CRC Press Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Name: Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 129.36 GBP
Availability: InStock

General Medical Issues

Price History & Forecast

Last 79 days • 79 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 79 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £129 (62 days, 78.5%)

Price range: £129 - £172

Price levels: 2 different prices over 79 days

Description

Product Description Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the mix-up use of interval hypotheses testing (i.e., the use of TOST) and confidence interval approach, a risk/benefit assessment for non-inferiority/similarity margin, PK/PD bridging studies with multiple references, the detection of possible reference product change over time, design and analysis of biosimilar switching studies, the assessment of sensitivity index for assessment of extrapolation across indications without collecting data from those indications not under study, and the feasibility and validation of non-medical switch post-approval.Key Features:Reviews withdrawn draft guidance on analytical similarity assessment.Evaluates various methods for analytical similarity evaluation based on FDA’s current guidelines.Provides a general approach for the use of n-of-1 trial design for assessment of interchangeability.Discusses the feasibility and validity of the non-medical switch studies.Provides innovative thinking for detection of possible reference product change over time.This book embraces innovative thinking of design and analysis for biosimilar studies, which are required for review and approval of biosimilar regulatory submissions. About the Author Sang Joon Lee, Ph.D., is a Senior Executive Vice President at Celltrion, inc. Dr. Lee was previously an assistant Professor at the University of New Mexico School of Medicine, and a Research Associate and Statistical Analyst at The University of Texas, M.D. Anderson Cancer Center. He received the B.S. degree in Statistics from Inha University, the M.S. degree in Statistics from the Seoul National University, and the Ph.D. degree in Statistics from Texas A&M University. Dr. Lee has authored or co-authored over 100 research papers and invited papers. Shein-Chung Chow, Ph.D., is a Professor at Duke University School of Medicine. Dr. Chow was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Executive Director at Covance, and Director and Department Head at Bristol-Myers Squibb. He received the B.S. degree in mathematics from East China Normal University, and the Ph.D. degree in Statistics from the University of Wisconsin-Madison. Dr. Chow has authored or co-authored over 310 methodology papers and 31 books.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 0367896346
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 24 September 2021
Listed Since: 31 March 2021

Barcode

No barcode data available

CRC Press Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Analytical Similarity Assessment in Biosimilar Product Development

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

CRC Press Statistical Approaches in Oncology Clinical Development

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Statistical Remedies for Medical Researchers (Springer Series in Pharmaceutical Statistics)

Contemporary Biostatistics with Biopharmaceutical Applications (ICSA Book Series in Statistics)

Empirical Likelihood Methods in Biomedicine and Health - CRC Press

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Modern Statistical Methods for Health Research (Emerging Topics in Statistics and Biostatistics)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Statistical Modeling for Degradation Data (ICSA Book Series in Statistics)

Monte-Carlo Simulation-Based Statistical Modeling (ICSA Book Series in Statistics)

Nonclinical Drug Administration: Formulations, Routes and Regimens for Solving Drug Delivery Problems in Animal Model Systems

Biosimilars Development Strategies: Fast to Market Approaches

Design and Analysis of Clinical Trials with Time-to-Event Endpoints (Chapman & Hall/CRC Biostatistics Series)

Statistics in the Health Sciences: Theory, Applications, and Computing

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)